MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Chen Lab Cheng Lab Contag Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab McConnell Moseley Lab Plevritis Lab Rao Lab Schnitzer Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment

Links

Employment Opportunities


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Faculty

Dean Felsher, M.D.
Collaborator: Project 2 & 6
Assistant Professor in Medicine, Division of Oncology Stanford University
CCSR 1105b
269 Campus Drive
Stanford, California, 94305-5151
Phone: (650) 498-5269
Fax: (650) 736-1454
Email: dfelsher@stanford.edu


Consultant Project 2, Assistant Professor in Medicine, Division of Oncology (Stanford)
Project Co-Leader: Project 6, Assistant Professor in Medicine, Division of Oncology (Stanford)

Dr. Felsher is internationally recognized for his work on the c-myc oncogene and its role in the initiation and maintenance of lymphoma. He represents the new breed of translational scientists who can develop mouse models of human cancer and translate understanding of basic cancer biology into advances in therapeutics. He has a project on multimodality imaging of oncogene-induced tumorogenesis as part of the Stanford ICMIC P50, a project on the characterization of gene expression programs of transformation of lymphoma as part of the Stanford ICBP grant, and a project on the role of the immune system in mediating tumor regression in the Stanford Lymphoma Program Project. His research is fundamental towards translating discoveries from bench to bedside. He is a pioneer in the use of small animal models to identify critical signaling pathways, gene expression programs and proteins products to diagnose and treat lymphoma. This should eventually help in developing and testing new therapies in mouse and in man.

[ Back ]
crumpnews events